Saliva-based COVID-19 DNA Aptamer Test

计划入组 200 人 · 首次发布于 2021 年 7 月 23 日

Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor

计划入组 14 人 · 首次发布于 2021 年 5 月 3 日

Phase II/III Study of Anti-VEGF in Neovascular AMD

计划入组 540 人 · 首次发布于 2001 年 8 月 6 日

ApIS(Aptamer)

ApRC

Trop-2 targeted aptamer-drug conjugate(Aptamer Sciences/PinotBio)

Aptamer Sciences, Inc.

South Korea

Procaps Group

Luxembourg

ROCHET GROUP

France

Aptamer Group Launches Radiopharmaceutical Program with Enhanced Stability Profile

Aptamer Group Secures New Development Contracts and Licensing Deal for Synthetic Antibody Alternatives

Aptamer and Invizius Partner to Develop Next-Generation Complement System Therapies Using Synthetic Binders